Comparison Between Different Doses of Steroids in COVID-19 Patients
NCT ID: NCT05279482
Last Updated: 2022-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
104 participants
OBSERVATIONAL
2022-01-19
2022-03-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome
NCT04323592
Corticosteroids in Severe COVID-19 (ASAP-ESICM/ESAIC Study)
NCT04866082
A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19
NCT04402060
Therapy With Hydrocortisone, Ascorbic Acid, Thamine in Patients With Sepsis
NCT04160676
Evaluation of the Role of Hydrocortisone Either Alone or Combined With Fludrocortisone in the Outcome of Septic Shock in Adults
NCT04492280
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous studies suggested that cytokine release syndrome could be involved in the pathophysiology of critical SARS.COV.2 resulting in death so early suppression of cytokine storm may be lifesaving in critical patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group treated with standard dose methyl prednisolone
patients with positive PCR and requiring oxygen therapy
observation for outcome of methylprednisolone dose
no intervention as it is retrospective study for outcome
group treated with mega dose methyl prednisolone
patients with positive PCR and requiring oxygen therapy
observation for outcome of methylprednisolone dose
no intervention as it is retrospective study for outcome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
observation for outcome of methylprednisolone dose
no intervention as it is retrospective study for outcome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Negative PCR
* Uncontrolled blood sugar or DKA
* Patients on long term steroids therapy
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amr M Hilal Abdou
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain shams university hospitals
Cairo, , Egypt
Faculty of medicine, Ain Shams University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS41/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.